The regulation of parathyroid hormone secretion and synthesis

Journal of the American Society of Nephrology

Volumn 22, Issue 2, 2011, Pages 216-224

  Kumar, Rajiv ^a   Thompson, James R ^b  

^a MAYO GRADUATE SCHOOL   (United States)

^b Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CALCIUM ION; CALCIUM SENSING RECEPTOR; CELL ENZYME; G PROTEIN COUPLED RECEPTOR; MESSENGER RNA; PARATHYROID HORMONE; PHOSPHORUS; RETINOIC ACID RECEPTOR; VITAMIN D RECEPTOR;

CALCIUM ABSORPTION; CALCIUM BLOOD LEVEL; CHRONIC KIDNEY FAILURE; DISEASE COURSE; HORMONE SYNTHESIS; HUMAN; PARATHYROID CELL; PARATHYROID HORMONE RELEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SECONDARY HYPERPARATHYROIDISM; SHORT SURVEY; TRANSCRIPTION REGULATION;

EID: 79551670370     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2010020186     Document Type: Short Survey

References (132)

1. Habener JF, Rosenblatt M, Potts JT Jr.: Parathyroid hormone: Biochemical aspects of biosynthesis, secretion, action, and metabolism. Physiol Rev 64: 985-1053, 1984
2. Potts JT: Parathyroid hormone: Past and present. J Endocrinol 187: 311-325, 2005
3. Kumar R: Metabolism of 1,25-dihydroxyvitamin D3. Physiol Rev 64: 478-504, 1984
4. DeLuca HF, Schnoes HK: Vitamin D: Recent advances. Annu Rev Biochem 52: 411-439, 1983
5. Gesek FA, Friedman PA: On the mechanism of parathyroid hormone stimulation of calcium uptake by mouse distal convoluted tubule cells. J Clin Invest 90: 749-758, 1992
6. Isakova T, Gutierrez O, Shah A, Castaldo L, Holmes J, Lee H, Wolf M: Postprandial mineral metabolism and secondary hyperparathyroidism in early CKD. J Am Soc Nephrol 19: 615-623, 2008 (Pubitemid 351355405)
7. Moranne O, Froissart M, Rossert J, Gauci C, Boffa JJ, Haymann JP, M'Rad MB, Jacquot C, Houillier P, Stengel B, Fouqueray B: Timing of onset of CKD-related metabolic complications. J Am Soc Nephrol 20: 164-171, 2009
8. Potts JT, Reita RE, Deftos LJ, Kaye MB, Richardson JA, Buckle RM, Aurbach GD: Secondary hyperparathyroidism in chronic renal disease. Arch Intern Med 124: 408-412, 1969
9. Johnson WJ, Goldsmith RS, Arnaud CD: Prevention and treatment of progressive secondary hyperparathyroidism in advanced renal failure. Med Clin North Am 56: 961-975, 1972
10. Kumar R: Renal osteodystrophy: A complex disorder. J Lab Clin Med 93: 895-898, 1979
11. Bricker NS, Slatopolsky E, Reiss E, Avioli LV: Caclium, phosphorus, and bone in renal disease and transplantation. Arch Intern Med 123: 543-553, 1969
12. Reiss E, Canterbury JM, Kanter A: Circulating parathyroid hormone concentration in chronic renal insufficiency. Arch Intern Med 124: 417-422, 1969
13. Danese MD, Kim J, Doan QV, Dylan M, Griffiths R, Chertow GM: PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis. Am J Kidney Dis 47: 149-156, 2006
14. Jadoul M, Albert JM, Akiba T, Akizawa T, Arab L, Bragg-Gresham JL, Mason N, Prutz KG, Young EW, Pisoni RL: Incidence and risk factors for hip or other bone fractures among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study. Kidney Int 70: 1358-1366, 2006
15. Rudser KD, de Boer IH, Dooley A, Young B, Kestenbaum B: Fracture risk after parathyroidectomy among chronic hemodialysis patients. J Am Soc Nephrol 18: 2401-2407, 2007
16. Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM: Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 15: 2208-2218, 2004
17. Slatopolsky E, Bricker NS: The role of phosphorus restriction in the prevention of secondary hyperparathyroidism in chronic renal disease. Kidney Int 4: 141-145, 1973
18. Slatopolsky E, Caglar S, Gradowska L, Canterbury J, Reiss E, Bricker NS: On the prevention of secondary hyperparathyroidism in experimental chronic renal disease using "proportional reduction" of dietary phosphorus intake. Kidney Int 2: 147-151, 1972
19. Slatopolsky E, Caglar S, Pennell JP, Taggart DD, Canterbury JM, Reiss E, Bricker NS: On the pathogenesis of hyperparathyroidism in chronic experimental renal insufficiency in the dog. J Clin Invest 50: 492-499, 1971
20. Slatopolsky E, Gradowska L, Kashemsant C, Keltner R, Manley C, Bricker NS: The control of phosphate excretion in uremia. J Clin Invest 45: 672-677, 1966
21. McCarthy JT, Kumar R: Behavior of the vitamin D endocrine system in the development of renal osteodystrophy. Semin Nephrol 6: 21-30, 1986
22. McCarthy JT, Kumar R: Renal osteodystrophy. Endocrinol Metab Clin North Am 19: 65-93, 1990
23. Brown AJ, Dusso A, Lopez-Hilker S, Lewis-Finch J, Grooms P, Slatopolsky E: 1,25-(OH)2D receptors are decreased in parathyroid glands from chronically uremic dogs. Kidney Int 35: 19-23, 1989 (Pubitemid 19047419)
24. Brown AJ, Zhong M, Finch J, Ritter C, McCracken R, Morrissey J, Slatopolsky E: Rat calcium-sensing receptor is regulated by vitamin D but not by calcium. Am J Physiol 270: F454-F460, 1996
25. Ritter CS, Finch JL, Slatopolsky EA, Brown AJ: Parathyroid hyperplasia in uremic rats precedes down-regulation of the calcium receptor. Kidney Int 60: 1737-1744, 2001
26. Ritter CS, Martin DR, Lu Y, Slatopolsky E, Brown AJ: Reversal of secondary hyperparathyroidism by phosphate restriction restores parathyroid calcium-sensing receptor expression and function. J Bone Miner Res 17: 2206-2213, 2002
27. Naveh-Many T, Bell O, Silver J, Kilav R: Cis and trans acting factors in the regulation of parathyroid hormone (PTH) mRNA stability by calcium and phosphate. FEBS Lett 529: 60-64, 2002
28. Naveh-Many T, Sela-Brown A, Silver J: Protein-RNA interactions in the regulation of PTH gene expression by calcium and phosphate. Nephrol Dial Transplant 14: 811-813, 1999 (Pubitemid 29155124)
29. Nechama M, Ben-Dov IZ, Briata P, Gherzi R, Naveh-Many T: The mRNA decay promoting factor K-homology splicing regulator protein post-transcriptionally determines parathyroid hormone mRNA levels. Faseb J 22: 3458-3468, 2008
30. Nechama M, Uchida T, Mor Yosef-Levi I, Silver J, Naveh-Many T: The peptidyl-prolyl isomerase Pin1 determines parathyroid hormone mRNA levels and stability in rat models of secondary hyperparathyroidism. J Clin Invest 119: 3102-3114, 2009
31. Dusso AS, Arcidiacono MV, Sato T, Alvarez-Hernandez D, Yang J, Gonzalez-Suarez I, Tominaga Y, Slatopolsky E: Molecular basis of parathyroid hyperplasia. J Ren Nutr 17: 45-47, 2007
32. Dusso AS, Sato T, Arcidiacono MV, Alvarez- Hernandez D, Yang J, Gonzalez-Suarez I, Tominaga Y, Slatopolsky E: Pathogenic mechanisms for parathyroid hyperplasia. Kidney Int Suppl S8-S11, 2006
33. Locatelli F, Cannata-Andia JB, Drueke TB, Horl WH, Fouque D, Heimburger O, Ritz E: Management of disturbances of calcium and phosphate metabolism in chronic renal insufficiency, with emphasis on the control of hyperphosphataemia. Nephrol Dial Transplant 17: 723-731, 2002 (Pubitemid 34521119)
34. Moe SM, Drueke TB: Management of secondary hyperparathyroidism: The importance and the challenge of controlling parathyroid hormone levels without elevating calcium, phosphorus, and calcium-phosphorus product. Am J Nephrol 23: 369-379, 2003
35. Block GA, Martin KJ, de Francisco AL, Turner SA, Avram MM, Suranyi MG, Hercz G, Cunningham J, Abu-Alfa AK, Messa P, Coyne DW, Locatelli F, Cohen RM, Evenepoel P, Moe SM, Fournier A, Braun J, McCary LC, Zani VJ, Olson KA, Drueke TB, Goodman WG: Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med 350: 1516-1525, 2004
36. Shoben AB, Rudser KD, de Boer IH, Young B, Kestenbaum B: Association of oral calcitriol with improved survival in nondialyzed CKD. J Am Soc Nephrol 19: 1613-1619, 2008
37. Fox J, Heath H 3rd: The "calcium clamp": Effect of constant hypocalcemia on parathyroid hormone secretion. Am J Physiol 240: E649-E655, 1981
38. Cantley LK, Russell J, Lettieri D, Sherwood LM: 1,25-Dihydroxyvitamin D3 suppresses parathyroid hormone secretion from bovine parathyroid cells in tissue culture. Endocrinology 117: 2114-2119, 1985
39. Russell J, Lettieri D, Sherwood LM: Suppression by 1,25(OH)2D3 of transcription of the pre-proparathyroid hormone gene. Endocrinology 119: 2864-2866, 1986
40. Silver J, Naveh-Many T, Mayer H, Schmelzer HJ, Popovtzer MM: Regulation by vitamin D metabolites of parathyroid hormone gene transcription in vivo in the rat. J Clin Invest 78: 1296-1301, 1986
41. Silver J, Russell J, Sherwood LM: Regulation by vitamin D metabolites of messenger ribonucleic acid for preproparathyroid hormone in isolated bovine parathyroid cells. Proc Natl Acad Sci U S A 82: 4270-4273, 1985 (Pubitemid 15053625)
42. Hofer AM, Brown EM: Extracellular calcium sensing and signalling. Nat Rev Mol Cell Biol 4: 530-538, 2003
43. Potts JT, Gardella TJ: Progress, paradox, and potential: Parathyroid hormone research over five decades. Ann N Y Acad Sci 1117: 196-208, 2007
44. Moallem E, Kilav R, Silver J, Naveh-Many T: RNA-Protein binding and post-transcriptional regulation of parathyroid hormone gene expression by calcium and phosphate. J Biol Chem 273: 5253-5259, 1998
45. Russell J, Bar A, Sherwood LM, Hurwitz S: Interaction between calcium and 1,25-dihydroxyvitamin D3 in the regulation of preproparathyroid hormone and vitamin D receptor messenger ribonucleic acid in avian parathyroids. Endocrinology 132: 2639-2644, 1993
46. Naveh-Many T, Friedlaender MM, Mayer H, Silver J: Calcium regulates parathyroid hormone messenger ribonucleic acid (mRNA), but not calcitonin mRNA in vivo in the rat. Dominant role of 1,25-dihydroxyvitamin D. Endocrinology 125: 275-280, 1989
47. Naveh-Many T, Silver J: Regulation of parathyroid hormone gene expression by hypocalcemia, hypercalcemia, and vitamin D in the rat. J Clin Invest 86: 1313-1319, 1990 (Pubitemid 20370440)
48. Hawa NS, O'Riordan JL, Farrow SM: Posttranscriptional regulation of bovine parathyroid hormone synthesis. J Mol Endocrinol 10: 43-49, 1993
49. Vadher S, Hawa NS, O'Riordan JL, Farrow SM: Translational regulation of parathyroid hormone gene expression and RNA: Protein interactions. J Bone Miner Res 11: 746-753, 1996
50. Habener JF, Kemper B, Potts JT Jr.: Calcium-dependent intracellular degradation of parathyroid hormone: A possible mechanism for the regulation of hormone stores. Endocrinology 97: 431-441, 1975
51. Morrissey JJ, Cohn DV: Secretion and degradation of parathormone as a function of intracellular maturation of hormone pools. Modulation by calcium and dibutyryl cyclic AMP. J Cell Biol 83: 521-528, 1979 (Pubitemid 10178657)
52. Roth SI, Raisz LG: Effect of calcium concentration on the ultrastructure of rat parathyroid in organ culture. Lab Invest 13: 331-345, 1964
53. Bai M, Quinn S, Trivedi S, Kifor O, Pearce SH, Pollak MR, Krapcho K, Hebert SC, Brown EM: Expression and characterization of inactivating and activating mutations in the human Ca2+o-sensing receptor. J Biol Chem 271: 19537-19545, 1996 (Pubitemid 26271631)
54. Rogers KV, Dunn CK, Conklin RL, Hadfield S, Petty BA, Brown EM, Hebert SC, Nemeth EF, Fox J: Calcium receptor messenger ribonucleic acid levels in the parathyroid glands and kidney of vitamin D-deficient rats are not regulated by plasma calcium or 1,25-dihydroxyvitamin D3. Endocrinology 136: 499-504, 1995
55. Canaff L, Hendy GN: Human calcium-sensing receptor gene. Vitamin D response elements in promoters P1 and P2 confer transcriptional responsiveness to 1,25-dihydroxyvitamin D. J Biol Chem 277: 30337-30350, 2002
56. Yao JJ, Bai S, Karnauskas AJ, Bushinsky DA, Favus MJ: Regulation of renal calcium receptor gene expression by 1,25-dihydroxyvitamin D3 in genetic hypercalciuric stone-forming rats. J Am Soc Nephrol 16: 1300-1308, 2005
57. Brown EM, Gamba G, Riccardi D, Lombardi M, Butters R, Kifor O, Sun A, Hediger MA, Lytton J, Hebert SC: Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid. Nature 366: 575-580, 1993
58. Brown EM, Hebert SC: Calcium-receptor-regulated parathyroid and renal function. Bone 20: 303-309, 1997
59. Brown EM, MacLeod RJ: Extracellular calcium sensing and extracellular calcium signaling. Physiol Rev 81: 239-297, 2001
60. Brown EM, Pollak M, Hebert SC: Molecular mechanisms underlying the sensing of extracellular Ca2+ by parathyroid and kidney cells. Eur J Endocrinol 132: 523-531, 1995
61. Brown EM, Pollak M, Hebert SC: The extracellular calcium-sensing receptor: Its role in health and disease. Annu Rev Med 49: 15-29, 1998
62. Brown EM, Pollak M, Riccardi D, Hebert SC: Cloning and characterization of an extracellular Ca(2+)-sensing receptor from parathyroid and kidney: New insights into the physiology and pathophysiology of calcium metabolism. Nephrol Dial Transplant 9: 1703-1706, 1994
63. Schwarz P, Larsen NE, Lonborg Friis IM, Lillquist K, Brown EM, Gammeltoft S: Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism associated with mutations in the human Ca2+-sensing receptor gene in three Danish families. Scand J Clin Lab Invest 60: 221-227, 2000
64. Pollak MR, Brown EM, Chou YH, Hebert SC, Marx SJ, Steinmann B, Levi T, Seidman CE, Seidman JG: Mutations in the human Ca(2+)-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell 75: 1297-1303, 1993 (Pubitemid 2030445)
65. Brown EM, Pollak M, Hebert SC: Sensing of extracellular Ca2+ by parathyroid and kidney cells: Cloning and characterization of an extracellular Ca(2+)-sensing receptor. Am J Kidney Dis 25: 506-513, 1995
66. Hebert SC: Bartter syndrome. Curr Opin Nephrol Hypertens 12: 527-532, 2003
67. Brown EM: Mutations in the calcium-sensing receptor and their clinical implications. Horm Res 48: 199-208, 1997
68. Chattopadhyay N, Mithal A, Brown EM: The calcium-sensing receptor: A window into the physiology and pathophysiology of mineral ion metabolism. Endocr Rev 17: 289-307, 1996
69. Bai M, Trivedi S, Brown EM: Dimerization of the extracellular calcium-sensing receptor (CaR) on the cell surface of CaR-transfected HEK293 cells. J Biol Chem 273: 23605-23610, 1998
70. Bai M, Trivedi S, Kifor O, Quinn SJ, Brown EM: Intermolecular interactions between dimeric calcium-sensing receptor monomers are important for its normal function. Proc Natl Acad Sci U S A 96: 2834-2839, 1999
71. Fan GF, Ray K, Zhao XM, Goldsmith PK, Spiegel AM: Mutational analysis of the cysteines in the extracellular domain of the human Ca2+ receptor: Effects on cell surface expression, dimerization and signal transduction. FEBS Lett 436: 353-356, 1998
72. Ward DT, Brown EM, Harris HW: Disulfide bonds in the extracellular calcium-polyvalent cation-sensing receptor correlate with dimer formation and its response to divalent cations in vitro. J Biol Chem 273: 14476-14483, 1998
73. Zhang Z, Sun S, Quinn SJ, Brown EM, Bai M: The extracellular calcium-sensing receptor dimerizes through multiple types of intermolecular interactions. J Biol Chem 276: 5316-5322, 2001
74. Guex N, Peitsch MC: SWISS-MODEL and the Swiss-PdbViewer: An environment for comparative protein modeling. Electrophoresis 18: 2714-2723, 1997 (Pubitemid 28059943)
75. Kelley LA, MacCallum RM, Sternberg MJ: Enhanced genome annotation using structural profiles in the program 3D-PSSM. J Mol Biol 299: 499-520, 2000
76. Kopp J, Schwede T: The SWISS-MODEL Repository of annotated three-dimensional protein structure homology models. Nucleic Acids Res 32: D230-D234, 2004 (Pubitemid 38081645)
77. Schwede T, Kopp J, Guex N, Peitsch MC: SWISS-MODEL: An automated protein homology-modeling server. Nucleic Acids Res 31: 3381-3385, 2003
78. Kunishima N, Shimada Y, Tsuji Y, Sato T, Yamamoto M, Kumasaka T, Nakanishi S, Jingami H, Morikawa K: Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor. Nature 407: 971-977, 2000
79. Tsuchiya D, Kunishima N, Kamiya N, Jingami H, Morikawa K: Structural views of the ligand-binding cores of a metabotropic glutamate receptor complexed with an antagonist and both glutamate and Gd3+. Proc Natl Acad Sci U S A 99: 2660-2665, 2002
80. Nemeth EF, Bennett SA: Tricking the parathyroid gland with novel calcimimetic agents. Nephrol Dial Transplant 13: 1923-1925, 1998
81. Nemeth EF: Calcimimetic and calcilytic drugs: Just for parathyroid cells? Cell Calcium 35: 283-289, 2004
82. Nemeth EF: Pharmacological regulation of parathyroid hormone secretion. Curr Pharm Des 8: 2077-2087, 2002
83. Mun HC, Franks AH, Culverston E, Krapcho K, Nemeth EF, Conigrave AD: The Venus Fly Trap domain of the extracellular Ca2+- sensing receptor is required for L-amino acid sensing. J Biol Chem 279: 51739-51744, 2004
84. Brown EM, Butters R, Katz C, Kifor O: Neomycin mimics the effects of high extracellular calcium concentrations on parathyroid function in dispersed bovine parathyroid cells. Endocrinology 128: 3047-3054, 1991
85. Brown EM, Vassilev PM, Quinn S, Hebert SC: G-protein-coupled, extracellular Ca(2+)- sensing receptor: A versatile regulator of diverse cellular functions. Vitam Horm 55: 1-71, 1999
86. Fox J, Lowe SH, Conklin RL, Petty BA, Nemeth EF: Calcimimetic compound NPS R-568 stimulates calcitonin secretion but selectively targets parathyroid gland Ca(2+) receptor in rats. J Pharmacol Exp Ther 290: 480-486, 1999 (Pubitemid 29344537)
87. Nemeth EF, Delmar EG, Heaton WL, Miller MA, Lambert LD, Conklin RL, Gowen M, Gleason JG, Bhatnagar PK, Fox J: Calcilytic compounds: Potent and selective Ca2+ receptor antagonists that stimulate secretion of parathyroid hormone. J Pharmacol Exp Ther 299: 323-331, 2001 (Pubitemid 32905150)
88. Nemeth EF, Fox J: Calcimimetic compounds: A direct approach to controlling plasma levels of parathyroid hormone in hyperparathyroidism. Trends Endocrinol Metab 10: 66-71, 1999
89. Nemeth EF, Steffey ME, Hammerland LG, Hung BC, Van Wagenen BC, DelMar EG, Balandrin MF: Calcimimetics with potent and selective activity on the parathyroid calcium receptor. Proc Natl Acad Sci U S A 95: 4040-4045, 1998
90. Block GA, Zeig S, Sugihara J, Chertow GM, Chi EM, Turner SA, Bushinsky DA: Combined therapy with cinacalcet and low doses of vitamin D sterols in patients with moderate to severe secondary hyperparathyroidism. Nephrol Dial Transplant 23: 2311-2318, 2008 (Pubitemid 351957604)
91. Silverberg SJ, Bilezikian JP: The diagnosis and management of asymptomatic primary hyperparathyroidism. Nat Clin Pract Endocrinol Metab 2: 494-503, 2006
92. Valle C, Rodriguez M, Santamaria R, Almaden Y, Rodriguez ME, Canadillas S, Martin-Malo A, Aljama P: Cinacalcet reduces the set point of the PTH-calcium curve. J Am Soc Nephrol 19: 2430-2436, 2008
93. Gowen M, Stroup GB, Dodds RA, James IE, Votta BJ, Smith BR, Bhatnagar PK, Lago AM, Callahan JF, DelMar EG, Miller MA, Nemeth EF, Fox J: Antagonizing the parathyroid calcium receptor stimulates parathyroid hormone secretion and bone formation in osteopenic rats. J Clin Invest 105: 1595-1604, 2000
94. Rubin MR, Bilezikian JP: New anabolic therapies in osteoporosis. Endocrinol Metab Clin North Am 32: 285-307, 2003
95. Hieronymus H, Silver PA: A systems view of mRNP biology. Genes Dev 18: 2845-2860, 2004
96. Tfelt-Hansen J, Chattopadhyay N, Yano S, Kanuparthi D, Rooney P, Schwarz P, Brown EM: Calcium-sensing receptor induces proliferation through p38 mitogen-activated protein kinase and phosphatidylinositol 3-kinase but not extracellularly regulated kinase in a model of humoral hypercalcemia of malignancy. Endocrinology 145: 1211-1217, 2004
97. Hjalm G, MacLeod RJ, Kifor O, Chattopadhyay N, Brown EM: Filamin-A binds to the carboxyl-terminal tail of the calcium-sensing receptor, an interaction that participates in CaR-mediated activation of mitogen-activated protein kinase. J Biol Chem 276: 34880-34887, 2001
98. Arthur JM, Lawrence MS, Payne CR, Rane MJ, McLeish KR: The calcium-sensing receptor stimulates JNK in MDCK cells. Biochem Biophys Res Commun 275: 538-541, 2000
99. Hobson SA, Wright J, Lee F, McNeil SE, Bilderback T, Rodland KD: Activation of the MAP kinase cascade by exogenous calcium-sensing receptor. Mol Cell Endocrinol 200: 189-198, 2003 (Pubitemid 36331926)
100. Ye CP, Yano S, Tfelt-Hansen J, MacLeod RJ, Ren X, Terwilliger E, Brown EM, Chattopadhyay N: Regulation of a Ca2+-activated K+ channel by calcium-sensing receptor involves p38 MAP kinase. J Neurosci Res 75: 491-498, 2004
101. Huang C, Wu Z, Hujer KM, Miller RT: Silencing of filamin A gene expression inhibits Ca2+-sensing receptor signaling. FEBS Lett 580: 1795-1800, 2006
102. Davies SL, Gibbons CE, Vizard T, Ward DT: Ca2+-sensing receptor induces Rho kinase-mediated actin stress fiber assembly and altered cell morphology, but not in response to aromatic amino acids. Am J Physiol Cell Physiol 290: C1543-C1551, 2006
103. Rey O, Young SH, Yuan J, Slice L, Rozengurt E: Amino acid-stimulated Ca2+ oscillations produced by the Ca2+-sensing receptor are mediated by a phospholipase C/inositol 1,4,5-trisphosphate-independent pathway that requires G12, Rho, filamin-A, and the actin cytoskeleton. J Biol Chem 280: 22875-22882, 2005
104. Zhang M, Breitwieser GE: High affinity interaction with filamin A protects against calcium-sensing receptor degradation. J Biol Chem 280: 11140-11146, 2005 (Pubitemid 40418420)
105. Loretz CA, Pollina C, Hyodo S, Takei Y, Chang W, Shoback D: cDNA cloning and functional expression of a Ca2+-sensing receptor with truncated C-terminal tail from the Mozambique tilapia (Oreochromis mossambicus). J Biol Chem 279: 53288-53297, 2004
106. Ward DT: Calcium receptor-mediated intracellular signalling. Cell Calcium 35: 217-228, 2004
107. Carfi A, Gong H, Lou H, Willis SH, Cohen GH, Eisenberg RJ, Wiley DC: Crystallization and preliminary diffraction studies of the ectodomain of the envelope glycoprotein D from herpes simplex virus 1 alone and in complex with the ectodomain of the human receptor HveA. Acta Crystallogr D Biol Crystallogr 58: 836-838, 2002
108. Awata H, Huang C, Handlogten ME, Miller RT: Interaction of the calcium-sensing receptor and filamin, a potential scaffolding protein. J Biol Chem 276: 34871-34879, 2001
109. Brown AJ, Ritter CS, Finch JL, Slatopolsky EA: Decreased calcium-sensing receptor expression in hyperplastic parathyroid glands of uremic rats: Role of dietary phosphate. Kidney Int 55: 1284-1292, 1999
110. Martin-Salvago M, Villar-Rodriguez JL, Palma-Alvarez A, Beato-Moreno A, Galera- Davidson H: Decreased expression of calcium receptor in parathyroid tissue in patients with hyperparathyroidism secondary to chronic renal failure. Endocr Pathol 14: 61-70, 2003 (Pubitemid 36605684)
111. Mathias RS, Nguyen HT, Zhang MY, Portale AA: Reduced expression of the renal calcium- sensing receptor in rats with experimental chronic renal insufficiency. J Am Soc Nephrol 9: 2067-2074, 1998
112. Yano S, Sugimoto T, Tsukamoto T, Chihara K, Kobayashi A, Kitazawa S, Maeda S, Kitazawa R: Association of decreased calcium-sensing receptor expression with proliferation of parathyroid cells in secondary hyperparathyroidism. Kidney Int 58: 1980-1986, 2000
113. Demay MB, Kiernan MS, DeLuca HF, Kronenberg HM: Sequences in the human parathyroid hormone gene that bind the 1,25- dihydroxyvitamin D3 receptor and mediate transcriptional repression in response to 1,25-dihydroxyvitamin D3. Proc Natl Acad Sci U S A 89: 8097-8101, 1992
114. McKee AE, Silver PA: Systems perspectives on mRNA processing. Cell Res 17: 581-590, 2007
115. Bentley DL: Rules of engagement: Co-transcriptional recruitment of pre-mRNA processing factors. Curr Opin Cell Biol 17: 251-256, 2005
116. Blencowe BJ: Alternative splicing: New insights from global analyses. Cell 126: 37-47, 2006
117. Kornblihtt AR, de la Mata M, Fededa JP, Munoz MJ, Nogues G: Multiple links between transcription and splicing. RNA 10: 1489-1498, 2004
118. Moore MJ: From birth to death: The complex lives of eukaryotic mRNAs. Science 309: 1514-1518, 2005
119. Sanchez-Diaz P, Penalva LO: Post-transcription meets post-genomic: The saga of RNA binding proteins in a new era. RNA Biol 3: 101-109, 2006
120. Singh R, Valcarcel J: Building specificity with nonspecific RNA-binding proteins. Nat Struct Mol Biol 12: 645-653, 2005
121. Barreau C, Paillard L, Osborne HB: AU-rich elements and associated factors: Are there unifying principles? Nucleic Acids Res 33: 7138-7150, 2005
122. Misquitta CM, Chen T, Grover AK: Control of protein expression through mRNA stability in calcium signalling. Cell Calcium 40: 329-346, 2006 (Pubitemid 44307907)
123. Schiavi SC, Belasco JG, Greenberg ME: Regulation of proto-oncogene mRNA stability. Biochim Biophys Acta 1114: 95-106, 1992
124. Schiavi SC, Wellington CL, Shyu AB, Chen CY, Greenberg ME, Belasco JG: Multiple elements in the c-fos protein-coding region facilitate mRNA deadenylation and decay by a mechanism coupled to translation. J Biol Chem 269: 3441-3448, 1994
125. Chen CY, Shyu AB: AU-rich elements: characterization and importance in mRNA degradation. Trends Biochem Sci 20: 465-470, 1995
126. Lebreton A, Tomecki R, Dziembowski A, Seraphin B: Endonucleolytic RNA cleavage by a eukaryotic exosome. Nature 456: 993-996, 2008
127. McPheeters DS, Cremona N, Sunder S, Chen HM, Averbeck N, Leatherwood J, Wise JA: A complex gene regulatory mechanism that operates at the nexus of multiple RNA processing decisions. Nat Struct Mol Biol 16: 255-264, 2009
128. Schilders G, Pruijn GJ: Biochemical studies of the mammalian exosome with intact cells. Methods Enzymol 448: 211-226, 2008
129. Kilav R, Bell O, Le SY, Silver J, Naveh-Many T: The parathyroid hormone mRNA 3′-untranslated region AU-rich element is an unstructured functional element. J Biol Chem 279: 2109-2116, 2004 (Pubitemid 38084484)
130. Kumar R: Pin1 regulates parathyroid hormone mRNA stability. J Clin Invest 119: 2887-2891, 2009
131. Shen ZJ, Esnault S, Malter JS: The peptidyl-prolyl isomerase Pin1 regulates the stability of granulocyte-macrophage colony-stimulating factor mRNA in activated eosinophils. Nat Immunol 6: 1280-1287, 2005 (Pubitemid 43045640)
132. Shen ZJ, Esnault S, Rosenthal LA, Szakaly RJ, Sorkness RL, Westmark PR, Sandor M, Malter JS: Pin1 regulates TGF-beta1 production by activated human and murine eosinophils and contributes to allergic lung fibrosis. J Clin Invest 118: 479-490, 2008 (Pubitemid 351206539)